These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 29192759)

  • 1. Sulfur Nanoparticles with Novel Morphologies Coupled with Brain-Targeting Peptides RVG as a New Type of Inhibitor Against Metal-Induced Aβ Aggregation.
    Sun J; Xie W; Zhu X; Xu M; Liu J
    ACS Chem Neurosci; 2018 Apr; 9(4):749-761. PubMed ID: 29192759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotective Effect of SLM, a Novel Carbazole-Based Fluorophore, on SH-SY5Y Cell Model and 3xTg-AD Mouse Model of Alzheimer's Disease.
    Wu X; Kosaraju J; Zhou W; Tam KY
    ACS Chem Neurosci; 2017 Mar; 8(3):676-685. PubMed ID: 28032988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gintonin, a ginseng-derived lysophosphatidic acid receptor ligand, attenuates Alzheimer's disease-related neuropathies: involvement of non-amyloidogenic processing.
    Hwang SH; Shin EJ; Shin TJ; Lee BH; Choi SH; Kang J; Kim HJ; Kwon SH; Jang CG; Lee JH; Kim HC; Nah SY
    J Alzheimers Dis; 2012; 31(1):207-23. PubMed ID: 22543851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Near-Infrared Photothermally Enhanced Photo-Oxygenation for Inhibition of Amyloid-β Aggregation Based on RVG-Conjugated Porphyrinic Metal-Organic Framework and Indocyanine Green Nanoplatform.
    Wang J; Gu Y; Liu X; Fan Y; Zhang Y; Yi C; Cheng C; Yang M
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SLOH, a carbazole-based fluorophore, mitigates neuropathology and behavioral impairment in the triple-transgenic mouse model of Alzheimer's disease.
    Wu X; Kosaraju J; Zhou W; Tam KY
    Neuropharmacology; 2018 Mar; 131():351-363. PubMed ID: 29309769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SEN1500, a novel oral amyloid-β aggregation inhibitor, attenuates brain pathology in a mouse model of Alzheimer's disease.
    Brunner D; Flunkert S; Neddens J; Duller S; Scopes DIC; Treherne JM; Hutter-Paier B
    Neurosci Lett; 2017 Nov; 660():96-102. PubMed ID: 28917978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrasound-Excited Protoporphyrin IX-Modified Multifunctional Nanoparticles as a Strong Inhibitor of Tau Phosphorylation and β-Amyloid Aggregation.
    Xu M; Zhou H; Liu Y; Sun J; Xie W; Zhao P; Liu J
    ACS Appl Mater Interfaces; 2018 Oct; 10(39):32965-32980. PubMed ID: 30192126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuronal mitochondria-targeted therapy for Alzheimer's disease by systemic delivery of resveratrol using dual-modified novel biomimetic nanosystems.
    Han Y; Chu X; Cui L; Fu S; Gao C; Li Y; Sun B
    Drug Deliv; 2020 Dec; 27(1):502-518. PubMed ID: 32228100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gd-nanoparticles functionalization with specific peptides for ß-amyloid plaques targeting.
    Plissonneau M; Pansieri J; Heinrich-Balard L; Morfin JF; Stransky-Heilkron N; Rivory P; Mowat P; Dumoulin M; Cohen R; Allémann É; Tόth É; Saraiva MJ; Louis C; Tillement O; Forge V; Lux F; Marquette C
    J Nanobiotechnology; 2016 Jul; 14(1):60. PubMed ID: 27455834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetically engineered exosomes display RVG peptide and selectively enrich a neprilysin variant: a potential formulation for the treatment of Alzheimer's disease.
    Yu Y; Li W; Mao L; Peng W; Long D; Li D; Zhou R; Dang X
    J Drug Target; 2021 Dec; 29(10):1128-1138. PubMed ID: 34182845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chiral gold nanoparticles enantioselectively rescue memory deficits in a mouse model of Alzheimer's disease.
    Hou K; Zhao J; Wang H; Li B; Li K; Shi X; Wan K; Ai J; Lv J; Wang D; Huang Q; Wang H; Cao Q; Liu S; Tang Z
    Nat Commun; 2020 Sep; 11(1):4790. PubMed ID: 32963242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of a Molecular Hybrid of Dual Peptide Inhibitors Coupled on AuNPs for Enhanced Inhibition of Amyloid β-Protein Aggregation and Cytotoxicity.
    Xiong N; Zhao Y; Dong X; Zheng J; Sun Y
    Small; 2017 Apr; 13(13):. PubMed ID: 28112856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gold nanoparticle-capped mesoporous silica-based H
    Yang L; Yin T; Liu Y; Sun J; Zhou Y; Liu J
    Acta Biomater; 2016 Dec; 46():177-190. PubMed ID: 27619837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biophysical, Biochemical, and Behavioral Implications of ApoE3 Conjugated Donepezil Nanomedicine in a Aβ
    Krishna KV; Saha RN; Dubey SK
    ACS Chem Neurosci; 2020 Dec; 11(24):4139-4151. PubMed ID: 33251785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual-functional nanoparticles for precise drug delivery to Alzheimer's disease lesions: Targeting mechanisms, pharmacodynamics and safety.
    Zheng X; Zhang C; Guo Q; Wan X; Shao X; Liu Q; Zhang Q
    Int J Pharm; 2017 Jun; 525(1):237-248. PubMed ID: 28432017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel 8-hydroxyquinoline derivatives targeting β-amyloid aggregation, metal chelation and oxidative stress against Alzheimer's disease.
    Yang X; Cai P; Liu Q; Wu J; Yin Y; Wang X; Kong L
    Bioorg Med Chem; 2018 Jul; 26(12):3191-3201. PubMed ID: 29729985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A modified preparation (LMK03) of the oriental medicine Jangwonhwan reduces Abeta(1-42) level in the brain of Tg-APPswe/PS1dE9 mouse model of Alzheimer disease.
    Seo JS; Jung EY; Kim JH; Lyu YS; Han PL; Kang HW
    J Ethnopharmacol; 2010 Aug; 130(3):578-85. PubMed ID: 20669372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effect of human serum albumin on Cu-induced Aβ(40) aggregation and toxicity.
    Lu N; Yang Q; Li J; Tian R; Peng YY
    Eur J Pharmacol; 2015 Nov; 767():160-4. PubMed ID: 26463036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of LVFFARK and LVFFARK-functionalized nanoparticles for inhibiting amyloid β-protein fibrillation and cytotoxicity.
    Xiong N; Dong XY; Zheng J; Liu FF; Sun Y
    ACS Appl Mater Interfaces; 2015 Mar; 7(10):5650-62. PubMed ID: 25700145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Dynamics Study on the Inhibition Mechanisms of Drugs CQ1-3 for Alzheimer Amyloid-β40 Aggregation Induced by Cu(2.).
    Dong M; Li H; Hu D; Zhao W; Zhu X; Ai H
    ACS Chem Neurosci; 2016 May; 7(5):599-614. PubMed ID: 26871000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.